Page last updated: 2024-11-10

nvp 231

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID4096211
CHEMBL ID4303283
CHEMBL ID4567342
SCHEMBL ID4252999
MeSH IDM0528722

Synonyms (35)

Synonym
n-(2-benzamido-1,3-benzothiazol-6-yl)adamantane-1-carboxamide
AKOS001615045
adamantane-1-carboxylic acid (2-benzoylamino-benzothiazol-6-yl)amide
362003-83-6
nvp-231
n-[2-(benzoylamino)-6-benzothiazolyl]-tricyclo[3.3.1.13,7]decane-1-carboxamide
S6501
nvp 231 ,
n-[2-(benzoylamino)-1,3-benzothiazol-6-yl]adamantane-1-carboxamide
gtpl6668
nvp231
MVSSJPGNLQPWSW-UHFFFAOYSA-N
adamantane-1-carboxylic acid (2-benzoylamino-benzothiazol-6-yl)-amide
CS-1808
HY-13945
SCHEMBL4252999
n-[2-(benzoylamino)-6-benzothiazolyl]-tricyclo[3.3.1.1(3,7)]decane-1-carboxamide
n-[2-(benzoylamino)-6-benzothiazolyl]tricyclo[3.3.1.13,7]decane-1-carboxamide
DTXSID40399268
n -[2-(benzoylamino)-6-benzothiazolyl]tricyclo[3.3.1.13,7]decane-1-carboxamide
sr-01000456438
SR-01000456438-1
EX-A709
AS-73454
nvp-231, >=98% (hplc)
mfcd01988824
FT-0700299
Q27088104
BCP15019
n-(2-benzamidobenzo[d]thiazol-6-yl)adamantane-1-carboxamide
CHEMBL4303283
CHEMBL4567342
AC-35988
(3r,5r,7r)-n-(2-benzamidobenzo[d]thiazol-6-yl)adamantane-1-carboxamide
PD063677
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1345952Human ceramide kinase (Ceramide kinase)2008Molecular pharmacology, Oct, Volume: 74, Issue:4
Targeting ceramide metabolism with a potent and specific ceramide kinase inhibitor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.19

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.19 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.19)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]